JP2021504420A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021504420A5 JP2021504420A5 JP2020529534A JP2020529534A JP2021504420A5 JP 2021504420 A5 JP2021504420 A5 JP 2021504420A5 JP 2020529534 A JP2020529534 A JP 2020529534A JP 2020529534 A JP2020529534 A JP 2020529534A JP 2021504420 A5 JP2021504420 A5 JP 2021504420A5
- Authority
- JP
- Japan
- Prior art keywords
- synthetic composition
- hmo
- human
- gastrointestinal
- human milk
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201700680 | 2017-11-30 | ||
| DKPA201700680 | 2017-11-30 | ||
| DKPA201700690 | 2017-12-05 | ||
| DKPA201700690 | 2017-12-05 | ||
| PCT/IB2018/059501 WO2019106620A1 (en) | 2017-11-30 | 2018-11-30 | Human milk oligosaccharides and synthetic compositions thereof for microbiota modulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021504420A JP2021504420A (ja) | 2021-02-15 |
| JP2021504420A5 true JP2021504420A5 (cg-RX-API-DMAC7.html) | 2022-01-06 |
Family
ID=66664406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020529534A Pending JP2021504420A (ja) | 2017-11-30 | 2018-11-30 | 微生物叢調節のためのヒトミルクオリゴ糖およびその合成組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20200323921A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3716983A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2021504420A (cg-RX-API-DMAC7.html) |
| KR (1) | KR102741265B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN111683665A (cg-RX-API-DMAC7.html) |
| BR (1) | BR112020010843A2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019106620A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11234992B2 (en) * | 2018-02-28 | 2022-02-01 | The Regents Of The University Of California | Methods and therapies for treating atherosclerosis and/or hyperlipidemia using oligosaccharides |
| JP2022513524A (ja) | 2018-12-19 | 2022-02-08 | グリコム・アクティーゼルスカブ | 低fodmap食を使用してヒトを治療するための組成物および方法 |
| US20220054515A1 (en) * | 2018-12-21 | 2022-02-24 | Glycom A/S | Composition and method for promoting intestinal barrier healing |
| EP3980025A4 (en) * | 2019-06-05 | 2023-06-14 | Glycom A/S | HUMAN MILK OLIGOSACCHARIDES FOR USE IN THE TREATMENT OF SYMPTOMS IN A PATIENT SUFFERING FROM NON-CELIAC GLUTEN AND/OR WHEAT SENSITIVITY |
| AU2020354581A1 (en) * | 2019-09-24 | 2022-03-03 | Prolacta Bioscience, Inc. | Compositions and methods for treatment of inflammatory and immune diseases |
| WO2021094993A1 (en) * | 2019-11-14 | 2021-05-20 | Glycom A/S | Synthetic composition for balancing the bile acid profile in the intestine |
| US11331329B2 (en) | 2020-05-13 | 2022-05-17 | Glycosyn LLC | Fucosylated oligosaccharides for prevention of coronavirus infection |
| EP4149482A4 (en) | 2020-05-13 | 2024-05-22 | Glycosyn LLC | 2'-FUCOSYLLACTOSE FOR THE PREVENTION AND TREATMENT OF CORONAVIRUS-INDUCED INFLAMMATION |
| US11896603B2 (en) * | 2020-06-12 | 2024-02-13 | The Regents Of The University Of California | Oligosaccharide as therapeutic agent for alcohol associated liver disease |
| JP2023536090A (ja) * | 2020-07-31 | 2023-08-23 | アボット・ラボラトリーズ | 脂肪肝疾患を予防、低減または遅延させる方法 |
| WO2022117829A1 (en) * | 2020-12-04 | 2022-06-09 | Société des Produits Nestlé S.A. | Compositions comprising human milk oligosaccharides for use in a subject to support night sleep duration |
| KR102456307B1 (ko) * | 2021-11-10 | 2022-10-19 | 충남대학교산학협력단 | 3’-시알릴락토오스, 6’-시알릴락토오스 또는 이의 염을 유효성분으로 포함하는 감염에 의한 다발성 장기부전의 예방 또는 치료용 조성물 |
| JP2023096870A (ja) * | 2021-12-27 | 2023-07-07 | 株式会社明治 | アッカーマンシア属細菌の増殖促進剤 |
| US20260165955A1 (en) | 2022-03-18 | 2026-06-18 | Meiji Co., Ltd. | Composition for controlling growth of bacteria of the genus collinsella and use thereof |
| CN115089596A (zh) * | 2022-06-20 | 2022-09-23 | 自然资源部第三海洋研究所 | 新琼寡糖用于制备治疗抑郁症产品的新用途 |
| WO2024126578A1 (en) * | 2022-12-13 | 2024-06-20 | Dsm Ip Assets B.V. | Synthetic composition comprising a human milk oligosaccharide for microbiota modulation |
| CN119138609B (zh) * | 2024-11-19 | 2025-02-25 | 飞鹤(吉林)乳品有限公司 | 母乳低聚糖改善母婴肠道菌群的用途 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005055944A2 (en) * | 2003-12-05 | 2005-06-23 | Cincinnati Children's Hospital Medical Center | Oligosaccharide compositions and use thereof in the treatment of infection |
| JP2012532195A (ja) * | 2009-07-06 | 2012-12-13 | チルドレンズ ホスピタル メディカル センター | 乳オリゴ糖による炎症の阻害 |
| EP2439264B1 (en) * | 2010-10-11 | 2015-06-03 | Jennewein Biotechnologie GmbH | Novel fucosyltransferases and their applications |
| MX356184B (es) * | 2010-12-31 | 2018-05-17 | Abbott Lab | Fórmulación pediátrica sintética que comprende un probiótico. |
| AU2012215042B2 (en) * | 2011-02-10 | 2016-01-14 | Société des Produits Nestlé S.A. | Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk |
| US20140187474A1 (en) * | 2011-02-16 | 2014-07-03 | The Board Of Trustees Of The Leland Stanford Junior University | Therapeutic use of mucin glycans |
| JP6129821B2 (ja) * | 2011-05-13 | 2017-05-17 | グリコシン リミテッド ライアビリティー カンパニー | プレバイオティクスとしての、精製された2’−フコシルラクトース、3−フコシルラクトース、およびラクトジフコテトラオースの使用 |
| NL2007268C2 (en) * | 2011-08-16 | 2013-02-19 | Friesland Brands Bv | Nutritional compositions comprising human milk oligosaccharides and uses thereof. |
| US10639319B2 (en) * | 2011-08-29 | 2020-05-05 | Abbott Laboratories | Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract |
| MX2014012362A (es) * | 2012-04-13 | 2015-05-07 | Trustees Boston College | Composición prebiótica y métodos de uso. |
| EP2842560A4 (en) * | 2012-04-23 | 2015-12-02 | Univ Kyoto | COMPOSITION TO PROMOTE THE GROWTH OF BIFIDOBAKTERIA |
| WO2014075745A1 (en) * | 2012-11-19 | 2014-05-22 | Université Catholique de Louvain | Use of akkermansia for treating metabolic disorders |
| GB201312713D0 (en) * | 2013-03-22 | 2013-08-28 | Weaver Connie M | Uses of soluble corn fibre for increasing colonic bacteria populations and increasing mineral absorption |
| WO2014201037A2 (en) * | 2013-06-10 | 2014-12-18 | New York University | Methods for manipulating immune responses by altering microbiota |
| CN107108677B (zh) * | 2014-10-24 | 2020-08-07 | 格礼卡姆股份公司 | Hmo的混合物 |
| US20170258820A1 (en) * | 2014-10-29 | 2017-09-14 | Glycom A/S | Synthetic composition and method for promoting mucosal healing |
| US20160287637A1 (en) * | 2014-12-08 | 2016-10-06 | Glycom A/S | Synthetic composition and method for modulating emotion and mood disorders |
| US10881674B2 (en) * | 2014-12-08 | 2021-01-05 | Glycom A/S | Synthetic composition for treating metabolic disorders |
| MX378680B (es) * | 2015-03-05 | 2025-03-11 | Soc Des Produits Nestle S A Star | Composiciones para usar en la prevencion o el tratamiento de infecciones/inflamaciones gastrointestinales en infantes o niños pequeños. |
| ES2886951T3 (es) * | 2015-09-14 | 2021-12-21 | Glycom As | Composición para su uso en la modulación de la microbiota |
| US10537597B2 (en) * | 2015-10-05 | 2020-01-21 | Schweizerisches Forschungsinstitut Fur Hochgebrigsklima Und Medizin In Davos | Use of Akkermansia muciniphila for treating inflammatory conditions |
| US10780103B2 (en) * | 2015-10-28 | 2020-09-22 | Glycom A/S | Synthetic composition and method for modulating emotion and mood disorders |
| CN108471793A (zh) * | 2016-01-26 | 2018-08-31 | 雀巢产品技术援助有限公司 | 用于婴儿或幼儿以预防或治疗变态反应的包含人乳低聚糖的组合物 |
| EP3589139A4 (en) * | 2017-03-01 | 2020-12-23 | Glycom A/S | SYNTHETIC COMPOSITION FOR MICROBIOTE MODULATION |
| WO2018207110A1 (en) * | 2017-05-09 | 2018-11-15 | Glycom A/S | Synthetic composition for microbiota modulation |
| US20180333426A1 (en) * | 2017-05-17 | 2018-11-22 | Mead Johnson Nutrition Company | Nutritional composition with human milk oligosaccharides and uses thereof |
| US11541068B2 (en) * | 2017-05-24 | 2023-01-03 | Glycom A/S | HMO compositions and methods for reducing autism spectrum disorder symptoms |
| EP3743078A4 (en) * | 2017-12-22 | 2022-01-19 | Glycom A/S | COMPOSITION WITH HMOs TO PREVENT OR REDUCE NOCICEPTION |
-
2018
- 2018-11-30 EP EP18882623.4A patent/EP3716983A4/en active Pending
- 2018-11-30 JP JP2020529534A patent/JP2021504420A/ja active Pending
- 2018-11-30 BR BR112020010843-0A patent/BR112020010843A2/pt unknown
- 2018-11-30 CN CN201880088085.XA patent/CN111683665A/zh active Pending
- 2018-11-30 WO PCT/IB2018/059501 patent/WO2019106620A1/en not_active Ceased
- 2018-11-30 KR KR1020207018744A patent/KR102741265B1/ko active Active
- 2018-11-30 US US16/768,414 patent/US20200323921A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Weber et al. | Dietary fiber mixture in pediatric patients with controlled chronic constipation | |
| JP2017533915A5 (cg-RX-API-DMAC7.html) | ||
| JP2014528474A5 (cg-RX-API-DMAC7.html) | ||
| JP2021504421A5 (cg-RX-API-DMAC7.html) | ||
| CN105106245A (zh) | Akkermansia muciniphila BAA-835菌株的应用 | |
| EP4255443A1 (en) | Stable semi-solid chewable gel compositions and methods of making and using thereof | |
| CN101686995A (zh) | Hiv患者肠内菌群的调节 | |
| JP2020178685A (ja) | 腸管障害の予防、治療又は抑制用組成物 | |
| Serra et al. | Prebiotic intake in older adults: effects on brain function and behavior | |
| CN103648504A (zh) | 用于预防或减小发生代谢综合征的风险的低聚糖组合物 | |
| Patil | A case series sharing novel experience of treating viral pandemic cases of morbid, mid aged, mild, moderate & severe grade with only Ayurvedic Medicines | |
| CN110448569B (zh) | 一种具有止泻功效的组合物及其制备方法和其应用 | |
| Mehjabin et al. | Role of inulin in the management of metabolic disorders | |
| US8840938B2 (en) | Bioavailability enhancing composition | |
| CN116568312A (zh) | 稳定的半固体可咀嚼凝胶组合物及其制作和使用方法 | |
| CN108653298A (zh) | 单糖组合物、药物制剂及其应用 | |
| WO2023284778A1 (zh) | 一种益生元组合物及其应用 | |
| CN105451749B (zh) | 吸附雄蜂幼虫匀浆和维生素d3或d族维生素和/或其活性代谢物在病毒性疾病的预防和治疗中的应用 | |
| JP2009013173A (ja) | いびき抑制剤 | |
| US20240358782A1 (en) | Regulatory Composition of the Neuro-Immune-Endocrine and Cortisol Reducing System of the Human Being | |
| JP6940265B2 (ja) | 止瀉剤組成物 | |
| JP2018522031A (ja) | 副鼻腔炎に対するイヌリンの予防的使用 | |
| Shapiro et al. | An evidence-based narrative review of oral supplements for the treatment of patients with irritable bowel syndrome | |
| US3150043A (en) | Anorectic composition | |
| JP4221266B2 (ja) | アレルギー性疾患の症状を抑制・緩和するための薬剤 |